Qualigen Therapeutics Inc

-0.06 (-3.33%)
Earnings Announcements, Equity Financing / Related

Qualigen Therapeutics Reports Q3 Financial Results And Provides Corporate Update

Published: 11/15/2022 12:48 GMT
Qualigen Therapeutics Inc (QLGN) - Qualigen Therapeutics, Inc. Reports Third Quarter 2022 Financial Results and Provides Corporate Update.
Qualigen Therapeutics Inc - Shareholders Approved Reverse Stock Split to Satisfy Nasdaq Continued Listing Qualifications.
Qualigen Therapeutics Inc - Believes Its Cash is Sufficient to Fund Its Anticipated Operations Into Q3 of 2023.
Qualigen Therapeutics Inc - Qtrly Loss per Share $0.10.
Revenue is expected to be $1.78 Million
Adjusted EPS is expected to be -$1.35

Next Quarter Revenue Guidance is expected to be $2 Million
Next Quarter EPS Guidance is expected to be -$1.30

More details on our Analysts Page.